Document is current
Any future updates will be listed below
-
Authors
Potere, Federica
Callera, Arianna
Confortola, Emma
Mansour, Nada Khaled
Micalizzi, Simone
De Danieli, Gianluca
Janssen, Pieter
Crippa, Alice
Oliva, Paolo
De Gaetano, Francesco https://orcid.org/0000-0002-7597-020X
-
Funding
Funding for this research was provided by:
Politecnico di Milano
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 20 March 2026
First Online: 10 April 2026
Declarations
:
: BetaGlue Therapeutics Spa funded this research. Authors Gianluca De Danieli, Pieter Janssen, and Alice Crippa are affiliated with BetaGlue Therapeutics Spa. The study investigates a phantom model intended for preclinical evaluation of injectable therapies, including YntraDose, a product developed by BetaGlue Therapeutics Spa. The company provided financial support and materials but had no role in data analysis, data interpretation, or the decision to submit the manuscript for publication. The remaining authors declare no competing interests.
: This study did not involve human participants, human data, or human tissue. Therefore, ethics approval and consent to participate were not required.
: Not applicable. This manuscript does not contain any individual person’s data in any form (including images, videos, or case details).
